Physician profile
Chin Lee
NPI 1033476072
$22,821.06
in general payments reported to CMS, 2019-2025
10 companies · $622 in 2025
The $622 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $975 · 2021: $222 · 2022: $67.17 · 2023: $271 · 2024: $473 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Travel and Lodging: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.27 |
| Travel and Lodging | $343.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,339.24 | 2019-2025 | Farapulse, General - Therapies |
| Biotronik INC. | $1,534.45 | 2019-2023 | |
| Abbott Laboratories | $1,475.42 | 2019-2021 | |
| Biosense Webster, INC. | $616.46 | 2019-2025 | Carto 3 |
| Medtronic, INC. | $499.60 | 2021-2024 | Attain Command + Surevalve, Selectsecure |
| Medical Device Business Services, INC. | $137.19 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.21 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $67.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.35 | 2019 | |
| Irhythm Technologies, INC. | $12.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.